Search For "drug controller general of india"
Union Minister Anupriya Patel inaugurates National Virus Research & Diagno
Updated : 7 months, 4 weeks ago IST
According to the release, the two-day event in Delhi saw the presence of Dr Rajiv Bahl, Secretary of the Department of Health Research (DHR) and DG, ICMR, and Dr Rajeev Singh Raghuvanshi, Drug Controller General of India.
Read More
Delhi HC directs DCGI to examine weight loss drug combinations, instructs
Updated : 11 months ago IST
The Delhi High Court has directed the Drug Controller General of India (DCGI) to examine and address issues raised in a petition challenging the approval and sale of certain weight loss drug combinations in India.
Read More
ENTOD meets Drug Controller General of India, issues clarification for Pre
Updated : 1 year, 8 months ago IST
Mumbai-based ENTOD Pharmaceuticals met with the Drug Controller General of India (DCGI) earlier this week to address concerns surrounding PresVu eye drops, which were approved for treating presbyopia in adults on August 6. However, the drug controller suspended its permission on September 10
Read More
New initiative by Drug Controller General of India to boost ease of doing
Updated : 2 years, 3 months ago IST
In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing the ease of doing business in India.
Read More
Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug,
Updated : 2 years, 4 months ago IST
Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular 10,11 anti-diabetic drug, Liraglutide, for the first time in India. The drug is being marketed under the brand name Liraf
Read More
AstraZeneca gets approval to import breast cancer treatment drug in India
Updated : 3 years ago IST
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatment of metastatic breast cancer.
Read More
Clinical features, treatment received by children are inadequate to determ
Updated : 3 years, 7 months ago IST
New Delhi [India], October 15 (ANI): Drugs Controller General of India (DCGI) on Saturday replied to World Health Organisation (WHO) and said as per the recently formed technical committee, the clinical features and the treatment received by the children as shared by WHO so far are inadeq
Read More
Corbevax approved as precaution dose for adults vaccinated with Covaxin, C
Updated : 3 years, 9 months ago IST
New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has approved Biological E's Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines
Read More
Corbevax heterologous COVID-19 booster expected to get final approval from
Updated : 3 years, 9 months ago IST
New Delhi [India], August 9 (ANI): The Union Government is considering giving its final approval to Corbevax's heterologous COVID-19 booster for 'Restricted Use in Emergency Situation' soon, sources said.
Read More
CBI arrests DCGI official in Rs 4 lakh bribery case
Updated : 3 years, 11 months ago IST
New Delhi [India], June 21 (ANI): The Central Bureau of Investigation (CBI) on Tuesday arrested one Drug Controller General of India (DCGI) official in the national capital for allegedly taking a bribe of Rs 4 lakh.
Read More
DCGI approves Corbevax as first heterologous COVID-19 booster shot for adu
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India], June 4 (ANI): Biological E. Limited, a Hyderabad-based pharmaceutical and vaccines company, on Saturday, announced that its Corbevax COVID-19 vaccine has been approved by the Drug Controller General of India (DCGI) as a heterologous COVID-19 booster dose for
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 4 years, 1 month ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More